ZA200204504B - Infant formula with improved protein content. - Google Patents

Infant formula with improved protein content. Download PDF

Info

Publication number: ZA200204504B
Authority: ZA; South Africa
Prior art keywords: protein; infant formula; component; infant; content
Prior art date: 1999-12-13

Application number

ZA200204504A

Other languages

English (en)

Inventor

Jacob Geert Bindels

Antonie Van Baalen

Robert Johan Joseph Hageman

Peti Huybers

Liliane Marie-Rose Louis Dumon

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-13

Filing date

2002-06-05

Publication date

2003-06-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240995&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200204504(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-06-05 Application filed by Nutricia Nv filed Critical Nutricia Nv

2003-06-05 Publication of ZA200204504B publication Critical patent/ZA200204504B/en

Links

235000013350 formula milk Nutrition 0.000 title claims description 216
235000018102 proteins Nutrition 0.000 claims description 50
102000004169 proteins and genes Human genes 0.000 claims description 50
108090000623 proteins and genes Proteins 0.000 claims description 50
239000000203 mixture Substances 0.000 claims description 41
239000011574 phosphorus Substances 0.000 claims description 36
229910052698 phosphorus Inorganic materials 0.000 claims description 36
108010009736 Protein Hydrolysates Proteins 0.000 claims description 31
239000000413 hydrolysate Substances 0.000 claims description 31
239000003531 protein hydrolysate Substances 0.000 claims description 31
IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 30
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 29
150000002632 lipids Chemical class 0.000 claims description 28
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 27
239000011575 calcium Substances 0.000 claims description 27
229910052791 calcium Inorganic materials 0.000 claims description 27
238000000034 method Methods 0.000 claims description 27
150000001413 amino acids Chemical class 0.000 claims description 26
229920001542 oligosaccharide Polymers 0.000 claims description 23
235000014113 dietary fatty acids Nutrition 0.000 claims description 18
229930195729 fatty acid Natural products 0.000 claims description 18
239000000194 fatty acid Substances 0.000 claims description 18
150000004665 fatty acids Chemical class 0.000 claims description 18
235000013406 prebiotics Nutrition 0.000 claims description 18
150000003626 triacylglycerols Chemical class 0.000 claims description 18
150000002482 oligosaccharides Chemical class 0.000 claims description 17
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 16
239000008101 lactose Substances 0.000 claims description 16
235000004252 protein component Nutrition 0.000 claims description 15
239000007858 starting material Substances 0.000 claims description 15
108010046377 Whey Proteins Proteins 0.000 claims description 13
102000007544 Whey Proteins Human genes 0.000 claims description 12
102000014171 Milk Proteins Human genes 0.000 claims description 11
108010011756 Milk Proteins Proteins 0.000 claims description 11
235000021239 milk protein Nutrition 0.000 claims description 11
238000002360 preparation method Methods 0.000 claims description 11
-1 sialyl oligosaccharides Chemical class 0.000 claims description 11
239000005018 casein Substances 0.000 claims description 10
239000005862 Whey Substances 0.000 claims description 9
150000004676 glycans Chemical class 0.000 claims description 9
229920001282 polysaccharide Polymers 0.000 claims description 9
239000005017 polysaccharide Substances 0.000 claims description 9
235000013336 milk Nutrition 0.000 claims description 8
239000008267 milk Substances 0.000 claims description 8
210000004080 milk Anatomy 0.000 claims description 8
102000011632 Caseins Human genes 0.000 claims description 7
108010076119 Caseins Proteins 0.000 claims description 7
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
235000021240 caseins Nutrition 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 7
108090000765 processed proteins & peptides Proteins 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 6
230000003301 hydrolyzing effect Effects 0.000 claims description 6
102000004196 processed proteins & peptides Human genes 0.000 claims description 6
241000196324 Embryophyta Species 0.000 claims description 4
239000000725 suspension Substances 0.000 claims description 4
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
210000005253 yeast cell Anatomy 0.000 claims description 4
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
235000010469 Glycine max Nutrition 0.000 claims description 3
AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 claims description 3
AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 claims description 3
USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 claims description 3
FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 claims description 2
229920001503 Glucan Polymers 0.000 claims description 2
244000068988 Glycine max Species 0.000 claims description 2
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims description 2
235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
229930193965 lacto-N-fucopentaose Natural products 0.000 claims description 2
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 2
229960000511 lactulose Drugs 0.000 claims description 2
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 2
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
239000000306 component Substances 0.000 description 132
238000006460 hydrolysis reaction Methods 0.000 description 27
230000007062 hydrolysis Effects 0.000 description 23
210000001035 gastrointestinal tract Anatomy 0.000 description 17
239000000843 powder Substances 0.000 description 15
230000002829 reductive effect Effects 0.000 description 14
235000019640 taste Nutrition 0.000 description 12
235000013305 food Nutrition 0.000 description 11
108090000790 Enzymes Proteins 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 10
150000001720 carbohydrates Chemical class 0.000 description 10
229940088598 enzyme Drugs 0.000 description 10
239000003925 fat Substances 0.000 description 10
235000019197 fats Nutrition 0.000 description 10
239000004615 ingredient Substances 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
229940088594 vitamin Drugs 0.000 description 9
229930003231 vitamin Natural products 0.000 description 9
235000013343 vitamin Nutrition 0.000 description 9
239000011782 vitamin Substances 0.000 description 9
238000012360 testing method Methods 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
229910052500 inorganic mineral Inorganic materials 0.000 description 7
239000011707 mineral Substances 0.000 description 7
235000010755 mineral Nutrition 0.000 description 7
235000013619 trace mineral Nutrition 0.000 description 7
239000011573 trace mineral Substances 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
235000014633 carbohydrates Nutrition 0.000 description 6
150000001768 cations Chemical class 0.000 description 6
210000002784 stomach Anatomy 0.000 description 6
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
235000021314 Palmitic acid Nutrition 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
238000001816 cooling Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 5
230000001771 impaired effect Effects 0.000 description 5
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 5
235000016709 nutrition Nutrition 0.000 description 5
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
229920001592 potato starch Polymers 0.000 description 5
229920006395 saturated elastomer Polymers 0.000 description 5
201000010538 Lactose Intolerance Diseases 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
206010067171 Regurgitation Diseases 0.000 description 4
102000005158 Subtilisins Human genes 0.000 description 4
108010056079 Subtilisins Proteins 0.000 description 4
235000008452 baby food Nutrition 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
235000019658 bitter taste Nutrition 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
210000003608 fece Anatomy 0.000 description 4
239000000835 fiber Substances 0.000 description 4
108010007119 flavourzyme Proteins 0.000 description 4
235000003599 food sweetener Nutrition 0.000 description 4
235000021317 phosphate Nutrition 0.000 description 4
150000003904 phospholipids Chemical class 0.000 description 4
239000000047 product Substances 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
239000000758 substrate Substances 0.000 description 4
239000003765 sweetening agent Substances 0.000 description 4
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
OVBPIULPVIDEAO-LBPRGKRZSA-N Folic acid Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
229920002774 Maltodextrin Polymers 0.000 description 3
229920002472 Starch Polymers 0.000 description 3
235000021355 Stearic acid Nutrition 0.000 description 3
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
229960001948 caffeine Drugs 0.000 description 3
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
229910001424 calcium ion Inorganic materials 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
210000001072 colon Anatomy 0.000 description 3
230000006378 damage Effects 0.000 description 3
210000002249 digestive system Anatomy 0.000 description 3
230000035611 feeding Effects 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
229940057917 medium chain triglycerides Drugs 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
230000002265 prevention Effects 0.000 description 3
238000012545 processing Methods 0.000 description 3
235000019698 starch Nutrition 0.000 description 3
239000008117 stearic acid Substances 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
229960004799 tryptophan Drugs 0.000 description 3
150000003721 vitamin K derivatives Chemical class 0.000 description 3
235000021119 whey protein Nutrition 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
206010052813 Aerophagia Diseases 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
102100026189 Beta-galactosidase Human genes 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
206010010774 Constipation Diseases 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
239000004129 EU approved improving agent Substances 0.000 description 2
101150007919 Gper1 gene Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
108010059881 Lactase Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
229920000881 Modified starch Polymers 0.000 description 2
208000007101 Muscle Cramp Diseases 0.000 description 2
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
239000005642 Oleic acid Substances 0.000 description 2
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
102000015636 Oligopeptides Human genes 0.000 description 2
108010038807 Oligopeptides Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
229930003448 Vitamin K Natural products 0.000 description 2
206010000059 abdominal discomfort Diseases 0.000 description 2
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000007815 allergy Effects 0.000 description 2
230000036528 appetite Effects 0.000 description 2
235000019789 appetite Nutrition 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
159000000007 calcium salts Chemical class 0.000 description 2
229940021722 caseins Drugs 0.000 description 2
150000001860 citric acid derivatives Chemical class 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
238000001035 drying Methods 0.000 description 2
210000001198 duodenum Anatomy 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
238000005886 esterification reaction Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
229960000304 folic acid Drugs 0.000 description 2
235000019152 folic acid Nutrition 0.000 description 2
239000011724 folic acid Substances 0.000 description 2
239000007789 gas Substances 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
235000020256 human milk Nutrition 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
229940116108 lactase Drugs 0.000 description 2
229960004452 methionine Drugs 0.000 description 2
238000002156 mixing Methods 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
235000021313 oleic acid Nutrition 0.000 description 2
229960002969 oleic acid Drugs 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
235000020610 powder formula Nutrition 0.000 description 2
238000011160 research Methods 0.000 description 2
235000003441 saturated fatty acids Nutrition 0.000 description 2
150000004671 saturated fatty acids Chemical class 0.000 description 2
238000004062 sedimentation Methods 0.000 description 2
239000008107 starch Substances 0.000 description 2
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
235000019168 vitamin K Nutrition 0.000 description 2
239000011712 vitamin K Substances 0.000 description 2
229940046010 vitamin k Drugs 0.000 description 2
DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 2
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
206010000060 Abdominal distension Diseases 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
239000004135 Bone phosphate Substances 0.000 description 1
241000283707 Capra Species 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
208000002881 Colic Diseases 0.000 description 1
206010011469 Crying Diseases 0.000 description 1
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
206010012444 Dermatitis diaper Diseases 0.000 description 1
208000003105 Diaper Rash Diseases 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
208000004262 Food Hypersensitivity Diseases 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010019670 Hepatic function abnormal Diseases 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
229930195722 L-methionine Natural products 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
102000012479 Serine Proteases Human genes 0.000 description 1
108010022999 Serine Proteases Proteins 0.000 description 1
108010073771 Soybean Proteins Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003779 Vitamin B12 Natural products 0.000 description 1
229930003471 Vitamin B2 Natural products 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
238000003556 assay Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
208000024330 bloating Diseases 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
229960004203 carnitine Drugs 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000003297 denaturating effect Effects 0.000 description 1
238000011033 desalting Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
235000021373 diet component Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
235000020669 docosahexaenoic acid Nutrition 0.000 description 1
229940090949 docosahexaenoic acid Drugs 0.000 description 1
210000001842 enterocyte Anatomy 0.000 description 1
230000032050 esterification Effects 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
235000020932 food allergy Nutrition 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005428 food component Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000003871 intestinal function Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000001788 irregular Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
230000000873 masking effect Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
229940098695 palmitic acid Drugs 0.000 description 1
230000004203 pancreatic function Effects 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002028 premature Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
206010037844 rash Diseases 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
235000020612 ready-to-feed formula Nutrition 0.000 description 1
229960002477 riboflavin Drugs 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
235000021391 short chain fatty acids Nutrition 0.000 description 1
150000004666 short chain fatty acids Chemical class 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940001941 soy protein Drugs 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
230000004206 stomach function Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
229960003080 taurine Drugs 0.000 description 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
125000005457 triglyceride group Chemical group 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
235000000112 undernutrition Nutrition 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019163 vitamin B12 Nutrition 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
235000019164 vitamin B2 Nutrition 0.000 description 1
239000011716 vitamin B2 Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
235000008939 whole milk Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pediatric Medicine (AREA)
Dairy Products (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Edible Oils And Fats (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

ZA200204504A 1999-12-13 2002-06-05 Infant formula with improved protein content. ZA200204504B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99204287A EP1062873A1 (en)	1999-12-13	1999-12-13	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate

Publications (1)

Publication Number	Publication Date
ZA200204504B true ZA200204504B (en)	2003-06-05

Family

ID=8240995

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200204504A ZA200204504B (en)	1999-12-13	2002-06-05	Infant formula with improved protein content.

Country Status (25)

Country	Link
US (1)	US6863918B2 (da)
EP (6)	EP1062873A1 (da)
JP (1)	JP4242589B2 (da)
CN (2)	CN1236682C (da)
AR (1)	AR027193A1 (da)
AT (3)	ATE290320T1 (da)
AU (1)	AU771010B2 (da)
BR (1)	BRPI0016341B1 (da)
CA (1)	CA2393269C (da)
CZ (1)	CZ304354B6 (da)
DE (3)	DE60044380D1 (da)
DK (3)	DK1237419T3 (da)
ES (3)	ES2344906T3 (da)
HK (3)	HK1049429B (da)
HU (1)	HU230659B1 (da)
MX (1)	MXPA02005851A (da)
NO (1)	NO325239B1 (da)
NZ (1)	NZ519513A (da)
PL (1)	PL199368B1 (da)
PT (3)	PT1557096E (da)
RU (1)	RU2243698C2 (da)
SK (2)	SK287402B6 (da)
TW (1)	TWI250848B (da)
WO (1)	WO2001041581A1 (da)
ZA (1)	ZA200204504B (da)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
JP3781606B2 (ja)	2000-04-04	2006-05-31	憲司中村	海綿動物タンパク質の加水分解物及びその製造方法
CN101342184B (zh) *	2000-12-27	2011-05-25	努特里奇亚有限公司	寡糖在制备营养或药物组合物中的用途
US6620427B2 (en) *	2001-04-24	2003-09-16	Abbott Laboratories	Method for improving bone mineralization
FR2827480B1 (fr) *	2001-07-17	2003-09-19	Cie Laitiere Europeenne	Lactoserum modifie, procede de preparation, utilisation et produit de panification comprenant le lactoserum modifie
MXPA04000480A (es)	2001-07-18	2004-07-23	Dsm Ip Assets Bv	Proceso para la hidrolisis de proteinas lacteas.
US20070281003A1 (en)	2001-10-12	2007-12-06	Fuisz Richard C	Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20110033542A1 (en)	2009-08-07	2011-02-10	Monosol Rx, Llc	Sublingual and buccal film compositions
US20190328679A1 (en)	2001-10-12	2019-10-31	Aquestive Therapeutics, Inc.	Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900498B2 (en)	2001-10-12	2014-12-02	Monosol Rx, Llc	Process for manufacturing a resulting multi-layer pharmaceutical film
US10285910B2 (en)	2001-10-12	2019-05-14	Aquestive Therapeutics, Inc.	Sublingual and buccal film compositions
US11207805B2 (en)	2001-10-12	2021-12-28	Aquestive Therapeutics, Inc.	Process for manufacturing a resulting pharmaceutical film
US7357891B2 (en)	2001-10-12	2008-04-15	Monosol Rx, Llc	Process for making an ingestible film
US8603514B2 (en)	2002-04-11	2013-12-10	Monosol Rx, Llc	Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20060039958A1 (en) *	2003-05-28	2006-02-23	Monosolrx, Llc.	Multi-layer films having uniform content
US8765167B2 (en)	2001-10-12	2014-07-01	Monosol Rx, Llc	Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en)	2001-10-12	2014-12-02	Monosol Rx, Llc	Process for making a film having a substantially uniform distribution of components
US20030203097A1 (en) *	2002-04-24	2003-10-30	The Procter & Gamble Company	Acidic compositions comprising protein and fiber and processes of their preparation
US7261911B2 (en)	2002-12-19	2007-08-28	Luebbers Steven T	Aseptically packaged, extensively hydrolyzed, liquid nutritional formula and method for making it
FR2859217B1 (fr) *	2003-09-03	2005-11-11	Rhodia Chimie Sa	Activateur pour ferment a base de bacteries lactiques et procede de preparation d'un produit mettant en oeuvre ledit activateur
GB0321996D0 (en) *	2003-09-19	2003-10-22	Novartis Nutrition Ag	Organic compounds
IL158555A0 (en) *	2003-10-22	2004-05-12	Enzymotec Ltd	Human breast milk lipid mimetic as dietary supplement
RU2373769C2 (ru) *	2003-10-24	2009-11-27	Н.В. Нютрисиа	Синбиотическая композиция для детей
EP1597978A1 (en) *	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
WO2006012536A2 (en)	2004-07-22	2006-02-02	Ritter Andrew J	Methods and compositions for treating lactose intolerance
PL1629850T5 (pl)	2004-08-24	2013-09-30	Nutricia Nv	Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy
US7666448B2 (en) *	2005-03-18	2010-02-23	Sakura Properties, Llc	Skin cleansing article
US7776365B2 (en) *	2005-03-18	2010-08-17	Sakura Properties, Llc	Article with skin protecting and moisturizing compound
US20060210496A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Compositions for skin protection from ultraviolet damage
US20060210688A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Dehydrated sports drink powder
US20060210697A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Infant formula composition
US20070020358A1 (en) *	2005-03-18	2007-01-25	Mower Thomas E	Sports drink concentrate
US20060210514A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Skin protection and moisturizing compositions and method of making the same
US20060210515A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Hair growth formula
US20060210692A1 (en) *	2005-03-18	2006-09-21	Mower Thomas E	Baby food composition
US7749545B2 (en) *	2005-03-18	2010-07-06	Sakura Properties, Llc	Fucoidan compositions and methods for dietary and nutritional supplements
US8119155B2 (en) *	2005-04-27	2012-02-21	N. V. Nutricia	Nutrition with lipids and non-digestible saccharides
JP2008538915A (ja) *	2005-04-27	2008-11-13	エンジィモテックリミテッド	ヒト乳脂代用物
US7618669B2 (en)	2005-06-01	2009-11-17	Mead Johnson Nutrition Company	Low-lactose partially hydrolyzed infant formula
US20060286208A1 (en) *	2005-06-01	2006-12-21	Nagendra Rangavajla	Methods for producing protein partial hydrolysates and infant formulas containing the same
US7572474B2 (en) *	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
SE528747C2 (sv) *	2005-06-23	2007-02-06	Forskarpatent I Syd Ab	Kaseinkomplex, smaklig produkt innehållande detsamma och förfarande för dess framställning
US8075934B2 (en)	2008-10-24	2011-12-13	Mead Johnson Nutrition Company	Nutritional composition with improved digestibility
US8287931B2 (en)	2005-06-30	2012-10-16	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
ES2350907T3 (es) *	2005-07-01	2011-01-28	N.V. Nutricia	Nutrición para bebés con proteínas hidrolizadas.
US20070166411A1 (en) *	2005-12-16	2007-07-19	Bristol-Myers Squibb Company	Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2008054192A1 (en)	2006-11-02	2008-05-08	N.V. Nutricia	Use of nutritional compositions for preventing disorders
EP1803358A1 (en)	2005-12-28	2007-07-04	Laboratorios Ordesa, S.L	Infant immunological formula
ATE475328T1 (de) *	2006-01-31	2010-08-15	Nestec Sa	Nährstoffzusammensetzung für säuglinge mit niedrigem geburtsgewicht
BRPI0708977A2 (pt) *	2006-03-23	2011-06-21	Nutricia Nv	uso de uma composição, e, composição
US20070243290A1 (en) *	2006-04-18	2007-10-18	Melody Thompson	Method of tailoring infant formulas to individual nutritional needs prior to use
KR100866974B1 (ko)	2007-03-07	2008-11-05	건국대학교 산학협력단	유청 단백질 가수분해물을 유효성분으로 포함하는 항암용식품조성물
SI2190304T1 (sl) *	2007-09-17	2012-04-30	Nutricia Nv	Prehranska formulacija z visoko energijsko vsebnostjo
KR101354547B1 (ko) †	2007-10-09	2014-01-22	엔지모테크 리미티드	위장 장애의 치료 및 장 발달 및 성숙의 촉진용의 지질 조성물
NZ584322A (en)	2007-11-07	2011-08-26	Mead Johnson Nutrition Co	A method for decreasing the bitterness of a hydrolyzed-protein or protein-free infant
US20100233198A1 (en) *	2007-11-08	2010-09-16	Nestec S.A.	Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2219476B1 (en)	2007-11-14	2016-04-20	Loders Croklaan B.V.	Infant formula composition
ES2715312T3 (es)	2007-11-26	2019-06-03	Nestec Sa	Sistema de nutrición infantil ajustado según edad
US9131721B2 (en)	2007-12-04	2015-09-15	Nestec S.A.	Gut microbiota in infants
US20110223248A1 (en) *	2007-12-12	2011-09-15	Ritter Pharmaceuticals, Inc.	Methods and compositions for treating lactose intolerance
ES2611203T3 (es) *	2007-12-21	2017-05-05	N.V. Nutricia	Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal
EP2252370B1 (en) *	2008-02-08	2018-03-14	N.V. Nutricia	Use of lipid-rich nutrition for the treatment of post-operative ileus
RU2498605C2 (ru) *	2008-06-13	2013-11-20	Н.В. Нютрисиа	Питательная композиция для грудных детей, рожденных с проведением кесарева сечения
EP2143340A1 (en) *	2008-07-07	2010-01-13	Nestec S.A.	A nutritional composition with free amino acids and structured lipids
US8498729B2 (en)	2008-08-29	2013-07-30	Smp Logic Systems Llc	Manufacturing execution system for use in manufacturing baby formula
BRPI0919718A2 (pt) *	2008-10-20	2015-08-18	Nestec Sa	Composição nutricional com propriedades antirregurgitação
US8986769B2 (en) *	2008-10-24	2015-03-24	Mead Johnson Nutrition Company	Methods for preserving endogenous TGF-β
MY169478A (en) *	2008-10-31	2019-04-12	Nutricia Nv	Nutritional composition for infants delivered via caesarean section
EP2452574A1 (en)	2010-11-15	2012-05-16	Nestec S.A.	Age-tailored nutritional formula with particularly adapted caloric density for young infants
WO2010068086A1 (en) *	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
US8425955B2 (en) *	2009-02-12	2013-04-23	Mead Johnson Nutrition Company	Nutritional composition with prebiotic component
WO2010098822A1 (en)	2009-02-24	2010-09-02	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
US8293264B2 (en) *	2009-05-11	2012-10-23	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
TW201121431A (en) *	2009-12-01	2011-07-01	Abbott Lab	Soy protein-based nutritional formula with superior stability
WO2011071367A1 (en)	2009-12-11	2011-06-16	N.V. Nutricia	Metabolic imprinting effects of structured lipids
US20110189342A1 (en) *	2010-02-01	2011-08-04	Jeong Hea-Seok	High-purity galactooligosaccharides and uses thereof
WO2011119023A1 (en)	2010-03-26	2011-09-29	N.V. Nutricia	Low protein infant formula with increased essential amino acids
NZ623342A (en)	2010-04-26	2014-12-24	Enzymotec Ltd	Methods and lipid compositions for promoting development of gut flora
WO2011137249A1 (en)	2010-04-28	2011-11-03	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
US20110293784A1 (en)	2010-05-28	2011-12-01	Anja Wittke	Milk-based nutritional compositions
SG183849A1 (en) *	2010-05-28	2012-10-30	Mead Johnson Nutrition Co	Nutritional compositions
WO2011150949A1 (en)	2010-06-04	2011-12-08	N.V. Nutricia	Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2575508B1 (en) *	2010-06-04	2019-01-09	N.V. Nutricia	Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP3338565A1 (en) *	2010-06-04	2018-06-27	N.V. Nutricia	Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
WO2012044155A1 (en) *	2010-09-28	2012-04-05	N.V. Nutricia	Fat composition for programming immune response
US9149959B2 (en)	2010-10-22	2015-10-06	Monosol Rx, Llc	Manufacturing of small film strips
FI123201B (fi)	2010-10-29	2012-12-14	Valio Oy	Maitopohjainen tuote ja valmistusmenetelmä
EP2452571A1 (en) *	2010-11-15	2012-05-16	Nestec S.A.	Array of complementary infant/young child nutritional compositions
EP2465509A1 (en) *	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
US8968722B2 (en) *	2010-12-29	2015-03-03	Mead Johnson Nutrition Company	Milk-based nutritional compositions containing lactoferrin and uses thereof
MX389785B (es)	2011-07-26	2025-03-18	Nucitec Sa De Cv	Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
EP2800480A2 (en) *	2011-11-10	2014-11-12	Nestec S.A.	Infant formula with high sn-2 palmitate and oligofructose
EP2802223B1 (en) *	2012-01-09	2017-05-03	N.V. Nutricia	Glutamine enriched nutritional composition for preterm infants
CN104284597B (zh) *	2012-03-12	2018-05-01	N·V·努特里奇亚	动物脱脂乳的人乳化的方法以及由此获得的产品
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
WO2014007606A1 (en) *	2012-07-05	2014-01-09	N.V. Nutricia	Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
MX2012010487A (es) *	2012-09-11	2014-03-26	Nucitec Sa De Cv	Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
MX2012010488A (es) *	2012-09-11	2014-03-26	Nucitec Sa De Cv	Formula infantil para el optimo crecimiento, proteccion gastrointestinal y proteccion inmunologica de infantes.
ES2767600T3 (es)	2012-11-23	2020-06-18	Nutricia Nv	Fórmulas que comprenden perfiles de aminoácidos optimizados
CN103907936B (zh) *	2013-01-06	2016-08-10	安琪酵母股份有限公司	一种高蛋白组合物及其制备方法和应用
EP2943082B1 (en) *	2013-01-09	2017-04-12	N.V. Nutricia	Improvement of cognitive function in preterm infants that are small for gestational age
US12150466B2 (en)	2013-11-04	2024-11-26	Nutricia N.V.	Fermented formula with non digestible oligosaccharides
WO2015067325A1 (en) *	2013-11-11	2015-05-14	N.V. Nutricia	Powdered nutritional composition with large lipid globules
WO2015086176A1 (en) *	2013-12-12	2015-06-18	Nestec S.A.	Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity
AU2014361224A1 (en)	2013-12-12	2016-05-19	Nestec S.A.	Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children
CN113331426A (zh)	2014-04-08	2021-09-03	雅培公司	使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2015154254A1 (en) *	2014-04-09	2015-10-15	Nestle (China) Ltd.	Gender specific synthetic nutritional compositions and nutritional systems comprising them
US20170105445A1 (en)	2014-05-19	2017-04-20	N.V. Nutricia	Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
US11877587B2 (en)	2014-12-19	2024-01-23	Societe Des Produits Nestle S.A.	Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid
DK3328214T3 (da)	2015-07-29	2020-04-27	Abbott Lab	Ernæringsprodukter med forbedret lipofil opløselighed og biotilgængelighed i en let blandbar form
AU2016374150A1 (en) *	2015-12-18	2018-04-26	Société des Produits Nestlé S.A.	Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
US10039805B1 (en)	2016-02-26	2018-08-07	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
US10617700B1 (en)	2016-02-26	2020-04-14	Michelle Ann Toothman	Vitamin supplement compositions with enhanced bioavailability
US11122833B1 (en)	2016-02-26	2021-09-21	Michelle Ann Toothman	Infant formulas having vitamin complexes with enhanced bioavailability
US11273131B2 (en)	2016-05-05	2022-03-15	Aquestive Therapeutics, Inc.	Pharmaceutical compositions with enhanced permeation
JP7653218B2 (ja)	2016-05-05	2025-03-28	アクエスティブセラピューティクスインコーポレイテッド	送達増強エピネフリン組成物
MX2019000228A (es) *	2016-07-06	2019-08-29	Building Block Nutritionals Llc	Formula nutricional.
RU2748279C2 (ru) *	2016-08-04	2021-05-21	Сосьете Де Продюи Нестле С.А.	Питательные композиции и детские смеси, содержащие смесь олигосахаридов и необязательно bifidobacterium lactis для профилактики, лечения или снижения степени тяжести диареи, не связанной с ротавирусом
RU2749672C2 (ru)	2016-08-05	2021-06-16	Сосьете Де Продюи Нестле С.А.	Состав липидов для применения у младенцев и детей младшего возраста, способствующий кишечному комфорту и оптимальному всасыванию жиров и кальция
CN113825411A (zh)	2019-05-17	2021-12-21	纽崔西亚公司	包含维生素a和非消化性低聚糖的组合物
SG11202111944SA (en) *	2019-05-27	2021-12-30	Frieslandcampina Nederland Bv	Nutritional composition
CN112369469A (zh) *	2019-11-15	2021-02-19	广州富诺营养科技有限公司	一种含有唾液酸的婴儿配方乳粉及其制备方法
CN111317139A (zh) *	2020-03-05	2020-06-23	山东北舟生物科技有限公司	一种含牡丹α亚麻酸油和肽的营养品及其制备方法
EP4164414A4 (en)	2020-06-15	2024-07-10	Building Block Nutritionals, LLC	NUTRITIONAL FORMULA
WO2022078679A1 (en) *	2020-10-13	2022-04-21	Frieslandcampina Nederland B.V.	Nutritional composition

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3649295A (en) *	1970-06-01	1972-03-14	American Home Prod	Humanized fat compositions and infant formulas thereof
US4834974A (en) *	1986-01-13	1989-05-30	Protein Technologies, Inc.	Immunologically active whey fraction and recovery process
US5000975A (en) *	1988-12-29	1991-03-19	American Home Products Corporation	Randomized palm oil fat composition for infant formulas
US5013569A (en) *	1990-05-21	1991-05-07	Century Laboratories, Inc.	Infant formula
ES2033193B1 (es) *	1990-10-30	1994-01-16	Ganadera Union Ind Agro	Mezcla grasa para nutricion infantil y de adultos.
US5601860A (en)	1990-11-30	1997-02-11	American Home Products Corporation	Corandomized fat compositions for infant formulas
EP0496456B1 (en) *	1991-01-23	1995-03-15	Unilever N.V.	Human milk fat substitutes
IE914558A1 (en) *	1991-02-28	1992-09-09	Abbott Lab	Isolation of proteins by ultrafiltration
US5486461A (en) *	1991-11-08	1996-01-23	Novo Nordisk A/S	Casein hydrolyzate and method for production of such casein hydrolyzate
NZ258207A (en) *	1992-11-30	1996-02-27	Morinaga Milk Industry Co Ltd	Whey protein with low phosphorus content
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases
AU679020B2 (en) *	1992-12-23	1997-06-19	Abbott Laboratories	Medical foods for the nutritional support of infant/toddler metabolic diseases
EP0698078B1 (en)	1993-05-13	1997-08-20	Loders Croklaan B.V.	Human milk fat replacers from interesterified blends of triglycerides
SK282289B6 (sk) *	1993-07-01	2002-01-07	�Tefan Rosipal	Adaptované mlieko hlavne na dojčenskú výživu a spôsob jeho výroby
CZ281096B6 (cs) *	1994-06-30	1996-06-12	Jindřich Mudr. Drsc. Mourek	Tuková složka mléčné výživy a dětská výživa
FR2723963B1 (fr) *	1994-08-31	1997-01-17	Gervais Danone Co	Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
EP0815210B1 (en)	1995-03-16	2004-06-02	Novozymes A/S	An enzyme with aminopeptidase activity
US6099871A (en) *	1995-06-01	2000-08-08	Bristol-Myers Squibb Company	Anti-regurgitation infant formula
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) *	1995-08-04	1999-06-24	Naamloze Vennootschap Nutricia, Zoetermeer	Diätfasern enthaltende Nahrungszusammensetzung
US5700513A (en) *	1996-01-19	1997-12-23	Abbott Laboratories	Liquid nutritional product containing improved stabilizer composition
US5837312A (en)	1996-09-20	1998-11-17	Abbott Laboratories	Debittered protein product having improved antigenicity and method for manufacture
PT843972E (pt) *	1996-11-20	2002-12-31	Nutricia Nv	Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico
FR2757022B1 (fr) †	1996-12-13	1999-03-05	Bel Fromageries	Nouveau procede d'enrobage pour produits alimentaires et les produits enrobes obtenus
US5906982A (en) *	1997-03-31	1999-05-25	Abbott Laboratories	Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en) *	1997-03-31	2000-04-04	Abbott Laboraties	Nutritional formulations containing oligosaccharides
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
US6162472A (en) *	1998-07-28	2000-12-19	University Of Virginia Patent Foundation	Nutritional formula for premature infants and method of making
NL1010770C2 (nl) *	1998-12-09	2000-06-13	Nutricia Nv	Preparaat dat oligosacchariden en probiotica bevat.

1999
- 1999-12-13 EP EP99204287A patent/EP1062873A1/en not_active Withdrawn
2000
- 2000-02-13 PT PT05075549T patent/PT1557096E/pt unknown
- 2000-12-13 ES ES05075390T patent/ES2344906T3/es not_active Expired - Lifetime
- 2000-12-13 SK SK851-2002A patent/SK287402B6/sk not_active IP Right Cessation
- 2000-12-13 AU AU32420/01A patent/AU771010B2/en not_active Expired
- 2000-12-13 MX MXPA02005851A patent/MXPA02005851A/es active IP Right Grant
- 2000-12-13 RU RU2002118715/13A patent/RU2243698C2/ru active
- 2000-12-13 EP EP05075390A patent/EP1535520B1/en not_active Revoked
- 2000-12-13 PT PT00991317T patent/PT1237419E/pt unknown
- 2000-12-13 DK DK00991317T patent/DK1237419T3/da active
- 2000-12-13 PL PL355943A patent/PL199368B1/pl unknown
- 2000-12-13 CA CA002393269A patent/CA2393269C/en not_active Expired - Lifetime
- 2000-12-13 DK DK05075390.4T patent/DK1535520T3/da active
- 2000-12-13 PT PT05075390T patent/PT1535520E/pt unknown
- 2000-12-13 US US10/149,986 patent/US6863918B2/en not_active Expired - Lifetime
- 2000-12-13 CZ CZ2002-2012A patent/CZ304354B6/cs not_active IP Right Cessation
- 2000-12-13 DE DE60044380T patent/DE60044380D1/de not_active Expired - Lifetime
- 2000-12-13 WO PCT/NL2000/000913 patent/WO2001041581A1/en active IP Right Grant
- 2000-12-13 AT AT00991317T patent/ATE290320T1/de active
- 2000-12-13 SK SK5023-2010A patent/SK288367B6/sk not_active IP Right Cessation
- 2000-12-13 CN CNB008171165A patent/CN1236682C/zh not_active Expired - Lifetime
- 2000-12-13 EP EP05075549A patent/EP1557096B1/en not_active Revoked
- 2000-12-13 DE DE60044266T patent/DE60044266D1/de not_active Expired - Lifetime
- 2000-12-13 DE DE60018604.0T patent/DE60018604T3/de not_active Expired - Lifetime
- 2000-12-13 ES ES00991317T patent/ES2238339T5/es not_active Expired - Lifetime
- 2000-12-13 AT AT05075390T patent/ATE466490T1/de active
- 2000-12-13 JP JP2001542764A patent/JP4242589B2/ja not_active Expired - Lifetime
- 2000-12-13 HU HU0203736A patent/HU230659B1/hu unknown
- 2000-12-13 AT AT05075549T patent/ATE464797T1/de active
- 2000-12-13 AR ARP000106604A patent/AR027193A1/es active IP Right Grant
- 2000-12-13 ES ES05075549T patent/ES2344907T3/es not_active Expired - Lifetime
- 2000-12-13 EP EP10185894A patent/EP2266414A3/en not_active Withdrawn
- 2000-12-13 NZ NZ519513A patent/NZ519513A/en not_active IP Right Cessation
- 2000-12-13 CN CN2005101271285A patent/CN1788615B/zh not_active Expired - Lifetime
- 2000-12-13 DK DK05075549.5T patent/DK1557096T3/da active
- 2000-12-13 EP EP00991317A patent/EP1237419B2/en not_active Expired - Lifetime
- 2000-12-13 EP EP10161802A patent/EP2208424A1/en not_active Ceased
- 2000-12-13 BR BRPI0016341A patent/BRPI0016341B1/pt active IP Right Grant
- 2000-12-21 TW TW089127573A patent/TWI250848B/zh not_active IP Right Cessation
2002
- 2002-06-05 ZA ZA200204504A patent/ZA200204504B/en unknown
- 2002-06-10 NO NO20022751A patent/NO325239B1/no not_active IP Right Cessation
2003
- 2003-03-05 HK HK03101628.5A patent/HK1049429B/zh not_active IP Right Cessation
2005
- 2005-11-24 HK HK05110635.5A patent/HK1076229A1/xx not_active IP Right Cessation
2006
- 2006-01-27 HK HK06101269.6A patent/HK1078442A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
US6863918B2 (en)	2005-03-08
EP2208424A1 (en)	2010-07-21
AU771010B2 (en)	2004-03-11
ES2238339T5 (es)	2013-04-09
CA2393269C (en)	2007-02-20
NO20022751L (no)	2002-08-12
SK50232010A3 (en)	2002-12-03
SK288367B6 (sk)	2016-07-01
PT1237419E (pt)	2005-07-29
ATE466490T1 (de)	2010-05-15
NZ519513A (en)	2004-07-30
EP2266414A3 (en)	2012-04-18
HU230659B1 (hu)	2017-06-28
DE60044380D1 (de)	2010-06-17
ES2238339T3 (es)	2005-09-01
EP1535520A1 (en)	2005-06-01
JP2003515354A (ja)	2003-05-07
CN1236682C (zh)	2006-01-18
DE60018604T3 (de)	2014-02-13
EP1237419B2 (en)	2012-12-12
DK1535520T3 (da)	2010-08-02
ATE464797T1 (de)	2010-05-15
CN1788615B (zh)	2010-05-26
JP4242589B2 (ja)	2009-03-25
HK1049429B (zh)	2005-05-20
PT1557096E (pt)	2010-07-27
NO20022751D0 (no)	2002-06-10
CZ304354B6 (cs)	2014-03-19
SK8512002A3 (en)	2002-12-03
WO2001041581A1 (en)	2001-06-14
NO325239B1 (no)	2008-03-03
BR0016341A (pt)	2002-08-27
CN1788615A (zh)	2006-06-21
ES2344907T3 (es)	2010-09-09
HUP0203736A3 (en)	2004-12-28
RU2002118715A (ru)	2004-02-10
SK287402B6 (sk)	2010-09-07
EP1062873A1 (en)	2000-12-27
DK1237419T3 (da)	2005-06-27
PL355943A1 (en)	2004-05-31
TWI250848B (en)	2006-03-11
US20030072865A1 (en)	2003-04-17
HUP0203736A2 (hu)	2003-03-28
DE60018604D1 (de)	2005-04-14
AU3242001A (en)	2001-06-18
BRPI0016341B1 (pt)	2016-04-19
CZ20022012A3 (cs)	2002-10-16
PL199368B1 (pl)	2008-09-30
DE60044266D1 (de)	2010-06-02
EP1557096A1 (en)	2005-07-27
MXPA02005851A (es)	2003-10-14
AR027193A1 (es)	2003-03-19
ATE290320T1 (de)	2005-03-15
EP1237419A1 (en)	2002-09-11
RU2243698C2 (ru)	2005-01-10
HK1076229A1 (en)	2006-01-13
EP1535520B1 (en)	2010-05-05
CN1409603A (zh)	2003-04-09
EP2266414A2 (en)	2010-12-29
DE60018604T2 (de)	2006-03-09
HK1049429A1 (en)	2003-05-16
EP1557096B1 (en)	2010-04-21
HK1078442A1 (en)	2006-03-17
ES2344906T3 (es)	2010-09-09
EP1237419B1 (en)	2005-03-09
CA2393269A1 (en)	2001-06-14
DK1557096T3 (da)	2010-06-14
PT1535520E (pt)	2010-08-02

Publication	Publication Date	Title
CA2393269C (en)	2007-02-20	Infant formula with improved protein content
CA2371696C (en)	2005-11-15	Composition for an infant formula having a low threonine content
MXPA96001956A (en)	1997-08-01	Formula infantil anti-regurgitac
JP2001510145A (ja)	2001-07-31	メチオニンを含有する栄養組成物
CN1303238A (zh)	2001-07-11	提供谷氨酰胺的方法
JP2750467B2 (ja)	1998-05-13	ペプチド混合物及び経腸栄養組成物
CA2177229A1 (en)	1996-12-02	Anti-regurgitation infant formula